Health In Tech, Inc. (HIT)

Health In Tech Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	30.72	19.49	19.15	5.77
Revenue Growth (YoY)	55.15%	1.77%	231.93%	-
Cost of Revenue	10.12	4.05	2.3	0.33
Gross Profit	20.61	15.44	16.85	5.44
Selling, General & Admin	17.23	11.64	11.46	4.44
Research & Development	1.99	2.81	2	0.79
Operating Expenses	19.22	14.45	13.46	5.23
Operating Income	1.38	0.99	3.38	0.21
Interest Expense	-	-0.5	-0	-0
Interest & Investment Income	0.33	0.12	0.04	-
Other Non Operating Income (Expenses)	0.29	0.27	-	-
Pretax Income	2.01	0.89	3.42	0.2
Income Tax Expense	0.57	0.22	0.95	0.12
Earnings From Discontinued Operations	-	-	1.48	-0.32
Net Income to Company	1.44	0.67	3.96	-0.24
Minority Interest in Earnings	-	-	-1.48	0.32
Net Income	1.44	0.67	2.48	0.08
Net Income to Common	1.44	0.67	2.48	0.08
Net Income Growth	-20.90%	-72.93%	3005.84%	-
Shares Outstanding (Basic)	55	52	52	48
Shares Outstanding (Diluted)	58	54	52	48
Shares Change (YoY)	4.01%	3.66%	7.54%	-
EPS (Basic)	0.03	0.01	0.05	0.00
EPS (Diluted)	0.02	0.01	0.05	0.00
EPS Growth	-35.14%	-79.10%	2788.89%	-
Gross Margin	67.07%	79.21%	87.97%	94.21%
Operating Margin	4.50%	5.08%	17.66%	3.56%
Profit Margin	4.68%	3.44%	12.93%	1.38%
EBIT	1.38	0.99	3.38	0.21
EBIT Margin	4.50%	5.08%	17.66%	3.56%
Effective Tax Rate	28.39%	24.58%	27.62%	60.33%
Revenue as Reported	30.72	19.49	19.15	5.77
Advertising Expenses	-	0.06	0.31	0.11

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q